Warning message

The subscription service is currently unavailable. Please try again later.
nova scotia
new brunswick

Over half of Canadian patients with MS report consuming cannabis


Most Canadians diagnosed with multiple sclerosis (MS) report using cannabis to mitigate their symptoms, according to data published in the journal Multiple Sclerosis and Related Disorders.


Cannabis 2.0 numbers in Canada continue to roll higher

Canadian flag

In February, $265.4 million of recreational cannabis products were sold in Canada, approx. 3% less than the amount that was  sold in January. 

The data comes after a few Canadian Licensed Producers (LPs)  reported quarterly financial results for the period that ended on December 31, 2021. We consider this to be a bearish indicator for Canadian LPs and will monitor how the sector continues to perform. (Technical 420)


Fire and Flower is a Canadian cannabis retailer that just keeps on building

Canadian flag

Earlier this week, we highlighted Indiva Limited (TSXV: NDVA) (OTCQX: NDVAF) after it reported fourth quarter financial results and today, we want to highlight a leading Canadian cannabis retailer after it reported earnings. 

The company, Fire & Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWD) reported $175.5 million of consolidated revenue for the 2021 fiscal year. $130.8 million of the revenue that was generated was from retail stores and we are bullish on how the management team has opened additional retail locations across Canada. (Technical 420)


The Canadian cannabis epidemic



In a recent report by the New York Times, the most populace city in Canada, Toronto, was described as the wild west of marijuana shops. According to the report, Ontario's provincial government permitted the shops, by emergency order, to keep operating during the COVID 19 pandemic, even during lockdowns.

During this period, to the investors' delight, shares and stocks of licensed medical marijuana growers in Canada have multiplied in price.

However, the marijuana business was already expected to flourish even before the pandemic started in 2019, right after Canada's Prime Minister, Justin Trudeau, to fulfill a campaign promise, introduced legislation to legalize the recreational use of marijuana in Canada.


Village Farms International to participate in A.G.P. Cannabis Conference on May 3, 2022


Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ: VFF) today announced Mandesh Dosanjh, President and Chief Executive Officer of the Company's Canadian cannabis subsidiary, Pure Sunfarms, will participate in a panel discussion titled A Close Look at the State of the Canadian Cannabis Market on Tuesday, May 3, 2022 at 10:00 a.m. ET at the A.G.P. Alliance Global Partners Spring Cannabis Conference.

A live webcast of each the available to the public on Village Farms' website in the Investors section under the Presentations & Events tab. The webcast presentation will be archived and available for 90 days on the Company's website.


Canna Cabana, the largest cannabis retail chain in Canada, is revolutionizing the industry with their low pricing


The growing industry of cannabis is a representation of its significance to many people around the world, for however they may use. The quest for legalization through the United States and in many other places around the globe has been an ongoing process throughout the years. However, there are some places that are already taking advantage of the more open market, including Canada.


Avicanna expands RHO PhytoTM Formulary with the introduction of cannabigerol products into the Canadian market

Avicanna Inc. a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that it will be expanding its RHO Phyto formulary in Canada with Cannabigerol formulations into medical and adult-use channels across Canada. Avicanna expands its trusted RHO Phyto brand to include several CBG formulations which will be made...

Avicanna introduces the rare cannabinoid CBG into its RHO Phyto product formulary which includes oral, sublingual, and transdermal formulations

RHO Phyto CBG products will be made available through various medical and adult-use channels across Canada by Q3 2022


Canadian patients using cannabis to treat anxiety and depression experienced improved outcomes: study

CT scans



Researchers find "statistically significant improvements" between baseline and follow-up scores after initiating medical cannabis treatment.



Researchers from Harvest Medicine in Calgary suggest their recent findings support the view that using medical cannabis can help with treating anxiety and depression.

Investigators wanted to shed light on what impact medical cannabis has on outcomes for patients experiencing anxiety or depression.

Based on information from 7,362 patients who received their medical cannabis documentation and allotment from the Calgary clinic, researchers noted improved outcomes after initiating medical cannabis treatment and at the one-year follow-up.


Truss CEO expecting summer of cannabis-infused beverages after category’s rocky debut

Cannabis Drink

When cannabis-infused drinks were legalized in Canada in 2020, pot producers expected the beverages to flow all summer as consumers flocked to the new category.

Those visions were dashed when the COVID-19 pandemic temporarily closed shops that March and the following year was spent contending with a mishmash of health regulations, but Dave Schlosser believes that long-awaited summer demand is on its way.

“We think this will be the summer of CIB — cannabis-infused beverages — as people want to get out, want to socialize, want to try new things,” said the newly named president and chief executive of Truss Beverage Co., a joint venture between brewing giant Molson Coors Canada and cannabis company Hexo Corp.


Tilray stock: 3 catalysts we're waiting for

pill bottles



Cannabis investors are anxiously waiting for these developments to happen.

Tilray  (TLRY) is a cannabis market leader in Canada and Europe. However, shares of the company — along with other pot stocks — have been on a losing streak in recent years.

This downward trend is due both to fading hopes that the U.S. and other governments will legalize marijuana and to general weakness in the market.

However, recently, cannabis investors have had a glimmer of hope. Here are three catalysts that could send Tilray's stock skyrocketing.


Subscribe to RSS - Canada